TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/25/08 13:25 | 1/17/08 | AVRX | Avalon Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Carter Kenneth C | MD | DO | P,CEO | S.a | -4 | 2.65 | 0 | -1 | -6 | 20 | D | |||||||||||||||
1/23/08 20:41 | 1/17/08 | AVRX | Avalon Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Carter Kenneth C | MD | DO | P,CEO | S | -5 | 2.53 | 0 | -2 | -7 | 28 | D | |||||||||||||||
1/23/08 20:41 | 1/23/08 | AVRX | Avalon Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Carter Kenneth C | MD | DO | P,CEO | P | 12 | 2.58 | 0 | 5 | 21 | 28 | D | |||||||||||||||
8/31/06 11:52 | 8/30/06 | AVRX | Avalon Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Carter Kenneth C | MD | DO | P,CEO | P | 9 | 2.99 | 0 | 3 | 12 | 28 | D | |||||||||||||||
8/24/06 17:00 | 8/22/06 | AVRX | Avalon Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Carter Kenneth C | MD | DO | P,CEO | P | 7 | 3.27 | 0 | 2 | 9 | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |